According to researchers from MIT and a team from two Boston hospitals, there is early evidence that shows that a wrist sensor may be promising as a means of measuring the severity of epileptic seizures. This information was posted in this week’s issue of Neurology.

This new study shows that the wrist sensor can measure the severity of epileptic seizures in a manner that is just as good as electroencephalograms (EEGs). This method has the added bonus of doing this without the use of electrodes on the scalp or electrical leads. So far, it is being said that the wrist sensor could collect useful information from patients while they go about their day, all without having to go to the hospital. If these results are confirmed, this device could help patients get medical help a good deal faster when they need it.

Epilepsy is an often debilitating condition that can cause patients serious brain injuries if seizures are not treated quickly. There are many drugs are used to try to prevent the seizures which characterize the condition. One of those drugs is Topamax. Topamax can cause birth defects in babies exposed to the drug in-utero. Some of those birth defects linked to Topamax include PPHN, oral clefts, neural tube defects and heart, lung and brain defects. The drug is also used to treat migraines; most recently it has been included as an active ingredient in the weight loss drug Qnexa. It is not recommended for pregnant women and women thinking of becoming pregnant to use Topamax.

If your baby was born with any of these birth defects after being exposed to Topamax during gestation, contact Greg Jones today for a free consultation. I am experienced at fighting Topamax lawsuits and may be able to help you recover money for your baby’s injuries.